Peter K. Gessner
About
In The Last Decade
Peter K. Gessner
38 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 148
- Cellular and Molecular Neuroscience 253
- Molecular Biology 251
- Pediatrics, Perinatology and Child Health 165
- Organic Chemistry 140
- Clinical Psychology 111
Countries citing papers authored by Peter K. Gessner
This map shows the geographic impact of Peter K. Gessner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter K. Gessner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter K. Gessner more than expected).
Fields of papers citing papers by Peter K. Gessner
This network shows the impact of papers produced by Peter K. Gessner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter K. Gessner. The network helps show where Peter K. Gessner may publish in the future.
Co-authorship network of co-authors of Peter K. Gessner
This figure shows the co-authorship network connecting the top 25 collaborators of Peter K. Gessner. A scholar is included among the top collaborators of Peter K. Gessner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter K. Gessner. Peter K. Gessner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 192 | |
| 2 | 42 | |
| 3 | 106 | |
| 4 | 64 | |
| 5 | 5 | |
| 6 | 4 | |
| 7 | 15 | |
| 8 | 33 | |
| 9 | Brain bufotenine from administered acetyl bufotenine comparison of its tremorgenic activity with that of n n di methyl tryptamine and 5 methoxy n n dimethyl tryptamine | 10 |
| 10 | 7 | |
| 11 | 23 | |
| 12 | 23 | |
| 13 | 75 | |
| 14 | 21 | |
| 15 | 22 | |
| 16 | 7 | |
| 17 | 30 | |
| 18 | 96 | |
| 19 | 23 | |
| 20 | 37 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.